Human cytomegalovirus downregulates the expression of human class I major histocompatibility complex (MHC) molecules by accelerating destruction of newly synthesized class I heavy chains. The HCMV genome contains at least two genes, US11 and US2, each of which encode a product sufficient for causing the dislocation of newly synthesized class I heavy chains from the lumen of the endoplasmic reticulum to the cytosol. Based on a comparison of their abilities to degrade the murine class I molecules H-2Kb, Kd, Db, Dd, and Ld, the US11 and US2 gene products have non-identical specificities for class I molecules. Specifically, in human astrocytoma cells (U373-MG) transfected with the US11 gene, the Kb, Db, Dd, and Ld molecules expressed via recombinant vaccinia virus are rapidly degraded, whereas in US2-transfected cells, only Db and Dd are significantly destabilized. The diversity in HCMV-encoded functions that interfere with class I–restricted presentation likely evolved in response to the polymorphism of the MHC.
Skip Nav Destination
Article navigation
20 January 1997
Article Contents
Brief Definitive Report|
January 20 1997
The HCMV Gene Products US11 and US2 Differ in Their Ability to Attack Allelic Forms of Murine Major Histocompatibility Complex (MHC) Class I Heavy Chains
Robert P. Machold,
Robert P. Machold
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
Emmanuel J.H.J. Wiertz,
Emmanuel J.H.J. Wiertz
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
Thomas R. Jones,
Thomas R. Jones
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
H.L. Ploegh
H.L. Ploegh
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
Robert P. Machold
,
Emmanuel J.H.J. Wiertz
,
Thomas R. Jones
,
H.L. Ploegh
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Address correspondence to Hidde Ploegh, Center for Cancer Research, MIT, 40 Ames St. E17-322, Cambridge, MA 02139.
This work was supported by National Institutes of Health grants R01-AI33456 and R01-AI07463-17, and by Boehringer-Ingelheim.
Received:
September 20 1996
Revision Received:
November 26 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (2): 363–366.
Article history
Received:
September 20 1996
Revision Received:
November 26 1996
Citation
Robert P. Machold, Emmanuel J.H.J. Wiertz, Thomas R. Jones, H.L. Ploegh; The HCMV Gene Products US11 and US2 Differ in Their Ability to Attack Allelic Forms of Murine Major Histocompatibility Complex (MHC) Class I Heavy Chains. J Exp Med 20 January 1997; 185 (2): 363–366. doi: https://doi.org/10.1084/jem.185.2.363
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement